Citius Pharmaceuticals, Inc. (CTXR) NASDAQ
0.60
-0.0307(-4.84%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.72M |
| Enterprise Value | 11.28M |
| P/E Ratio | -0.29 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.2 |
| Price/Book Ratio | 0.22 |
| Enterprise/Revenue | 0.53 |
| Enterprise/EBITDA | -0.05 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -8.23 |
| Operating Margin | -10.41 |
Management Effectiveness
| Return On Assets | -0.35 |
| Return On Equity | -0.67 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.25 |
| Gross Profit | -214,250 |
| EBITDA | -38.2M |
| Net Income | -37.43M |
| Diluted EPS | -3.38 |
Balance Sheet
| Total Cash | 4.59M |
| Total Cash/Share | 0.21 |
| Total Debt | 808,162 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 0.58 |
| Book Value Per Share | 3.09 |
Price History
| 52-Week Change | -21.63 |
| 52-Week High | 2.48 |
| 52-Week Low | 0.48 |
| Moving Average 50 Days | 0.73 |
| Moving Average 200 Days | 1 |
Statistics
| Average Volume | 828,157 |
| Shares Outstanding | 11.17M |
| % Held by Institutions | 4.64 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | June 09, 2017 |
